Epstein Secrets

g Of Task Force. In an article titled "Under Pence, Politics Regularly Seeped Into The Coronavirus Task Force," the New York Times (10/8, Mazzetti, Weiland, Stolberg, 18.61M) reports that Vice President Pence's "decision to walk the halls of the Mayo Clinic without a mask" on April 28 is "only one examp

touted an experimental antibody treatment as a cure for COVID...two companies who make the treatments applied for emergency authority from the FDA. Eli Lilly and Regeneron say their antibodies made in the lab mimic the way the immune system fights infection." Dahlgren said Regeneron's early trials data "

he Coronavirus Task Force," the New York Times <https://www.nytimes.corn/2020/10/08/us/politics/pence-coronavirus-task-force.html> (10/8, Mazzetti, Weiland, Stolberg, 18.61M) reports that Vice President Pence's "decision to walk the halls of the Mayo Clinic without a mask" on April 28 is "only one examp

touted an experimental antibody treatment as a cure for COVID...two companies who make the treatments applied for emergency authority from the FDA. Eli Lilly and Regeneron say their antibodies made in the lab mimic the way the immune system fights infection." Dahlgren said Regeneron's early trials data "f

oses. Those people, like several others, spoke on the condition of anonymity to describe internal matters." The New York Times (1/26, Al, Stolberg, Weiland, LaFraniere, 20.6M) says that while Biden "said the moves were `going to allow millions more Americans to get vaccinated sooner than previously ant

to fight COVID-19, suggesting they can help keep patients out of the hospital and possibly prevent illness in some uninfected people." On Tuesday, Eli Lilly said that a "two-antibody combo reduced the risk of hospitalizations or death by 70% in newly diagnosed, non-hospitalized COVID-19 patients at high

g Of Task Force. In an article titled "Under Pence, Politics Regularly Seeped Into The Coronavirus Task Force," the New York Times (10/8, Mazzetti, Weiland, Stolberg, 18.61M) reports that Vice President Pence's "decision to walk the halls of the Mayo Clinic without a mask" on April 28 is "only one exam

touted an experimental antibody treatment as a cure for COVID...two companies who make the treatments applied for emergency authority from the FDA. Eli Lilly and Regeneron say their antibodies made in the lab mimic the way the immune system fights infection." Dahlgren said Regeneron's early trials data "

tiviral drug." Research On Plasma Infusions To Treat COVID Hampered By Demand, Government Program. EFTA00160730 The New York TiMPi (8/4, Thomas, Weiland, 18.61M) reports, "Since April, the Trump administration has funneled $48 million into a program with the Mayo Clinic, allowing more than 53,000 Co

Lilly Seeking Volunteers For Antibody Drug Trials. On NBC Nightly NewsVi (8/4, story 8, 1:45, 6.1M), Tom Costello reported, "The NIH and drugmaker Eli Lilly are tonight looking for 2,000 volunteers for antibody drug trials to treat patients suffering from the ravages of COVID. One trial involves patients

g Of Task Force. In an article titled "Under Pence, Politics Regularly Seeped Into The Coronavirus Task Force," the New York Times (10/8, Mazzetti, Weiland, Stolberg, 18.61M) reports that Vice President Pence's "decision to walk the halls of the Mayo Clinic without a mask" on April 28 is "only one exam

touted an experimental antibody treatment as a cure for COVID...two companies who make the treatments applied for emergency authority from the FDA. Eli Lilly and Regeneron say their antibodies made in the lab mimic the way the immune system fights infection." Dahlgren said Regeneron's early trials data "